Abstract:Transient receptor potential melastatin 2 (TRPM2), a non-selective cation channel, is involved in many physiological and pathological processes, including temperature sensing, synaptic plasticity regulation, and neurodegenerative diseases. However, the gating mechanism of TRPM2 channel is complex, which hinders its functional research. With the discovery of the Ca2+ binding site in the S2-S3 domain of TRPM2 channel, more and more attention has been drawn to the role of the transmembrane segments in channel gating. In this study, we focused on the D820-F867 segment around the S2 domain, and identified the key residues on it. Functional assays of the deletion mutants displayed that the deletions of D820-W835 and L836-P851 destroyed channel function totally, indicating the importance of these two segments. Sequence alignments on them found three polar and charged residues with high conservation (D820, E829, and R845). D820A, E829A, and R845A which removed the charge and the side chain of the residues were tested by 500 mu M adenosine diphosphate-ribose (ADPR) or 50 mM Ca2+. E829A and R845A affected the characteristic of channel currents, while D820A behaved similarly to WT, indicating the participations of E829 and R845 in channel gating. The charge reversing mutants, E829K and R845D were then constructed and the electrophysiological tests showed that E829A and E829K made the channel lose function. Interestingly, R845A and R845D exhibited an inactivation process when using 500 mu M ADPR, but activated normally by 50 mM Ca2+. Our data suggested that the negative charge at E829 took a vital part in channel activation, and R845 increased the stability of the Ca2+ combination in S2-S3 domain, thus guaranteeing the opening of TRPM2 channel. In summary, our identification of the key residues E829 and R845 in the transmembrane segments of TRPM2. By exploring the gating process of TRPM2 channel, our work helps us better understand the mechanism of TRPM2 as a potential biomarker in neurodegenerative diseases, and provides a new approach for the prediction, diagnosis, and prognosis of neurodegenerative diseases.

Key domains and residues of the receptor MRGPRX1 recognizing the peptide ligand BAM8-22

Bombyx neuropeptide G protein-coupled receptor A14 and A15 are two functional G protein-coupled receptors for CCHamide neuropeptides

Mechanism of agonist-induced activation of the human itch receptor MRGPRX1

Ligand recognition and G protein coupling of the human itch receptor MRGPRX1

Structure, function and pharmacology of human itch receptor complexes

Structures of Human Gastrin-Releasing Peptide Receptors Bound to Antagonist and Agonist for Cancer and Itch Therapy.

MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs

Activation of Mas Oncogene-Related G Protein–Coupled Receptors Inhibits Neurochemical Alterations in the Spinal Dorsal Horn and Dorsal Root Ganglia Associated with Inflammatory Pain in Rats

In silico design of novel probes for the atypical opioid receptor MRGPRX2

Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

Mas-Related Gene (mrg) C Activation Attenuates Bone Cancer Pain Via Modulating Gi and NR2B

The Origin, Expression, Function and Future Research Focus of a G Protein-coupled Receptor, Mas-related Gene X2 (MrgX2)

Mechanisms of Compartmentalized Expression of Mrg Class G-protein-coupled Sensory Receptors.

MRGPRX4 mediates phospho-drug–associated pruritus in a humanized mouse model

Molecular Recognition of Itching Neuropeptides by Bombesin Receptors

Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.

Mas-Related G-Protein-Coupled Receptor C Agonist Bovine Adrenal Medulla 8-22 Attenuates Bone Cancer Pain in Mice

Development of an Environmentally Sensitive Fluorescent Peptide Probe for MrgX2 and Application in Ligand Screening of Peptide Antibiotics.

MRGPRX4 is a novel bile acid receptor in cholestatic itch

Activation of Spinal Mrgc-Gi-Nr2b-Nnos Signaling Pathway by Mas Oncogene-Related Gene C Receptor Agonist Bovine Adrenal Medulla 8-22 Attenuates Bone Cancer Pain in Mice